Corporate insider profile
Frances Arnold Insider Trades
Frances Arnold has reported no open-market purchases on SEC Form 4 and is a net seller of $423,358 across 2 companies. The most recent open-market transaction was reported on Oct 29, 2026. Source: SEC Form 4 filings.
Latest reported as Director of Generate Biomedicines, Inc. (GENB).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 2
- Net open-market value
- -$423,358.30
- Latest transaction
- Oct 29, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Frances Arnold insider trading FAQ
- Is Frances Arnold buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Frances Arnold is a net seller of $423,358, with no open-market purchases reported. The latest transaction was reported on Oct 29, 2026.
- Which companies does Frances Arnold report insider trades for?
- Frances Arnold has reported open-market trades in Generate Biomedicines, Inc. (GENB), Alphabet Inc. (GOOGL). The latest SEC-reported relationship is Director of Generate Biomedicines, Inc. (GENB).
- Where does Frances Arnold's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1665419, and refreshes this page daily.
